The iconic rise of copyright’s flagship product presented a massive opportunity for the market, but its period has expired , creating a complex landscape. Off-brand versions have entered the space , cutting into sales and putting a strain on profit yields. While major drug companies hold a stake in this field , the future remains clouded by ongoi